<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00944866</url>
  </required_header>
  <id_info>
    <org_study_id>C07146</org_study_id>
    <nct_id>NCT00944866</nct_id>
  </id_info>
  <brief_title>Effects of Cox-II Inhibitor on Biochemical Markers in Cardiovascular-related Adverse Effects</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Chung Hsing University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Chung Hsing University</source>
  <brief_summary>
    <textblock>
      The selective cyclooxygenase-2 (COX-2) inhibitors have been associated with increased&#xD;
      cardiovascular risk. The goal of the present study is to investigate the impacts of COX-2&#xD;
      inhibitors on biochemical indices in cardiovascular disease. As the reviewer suggested, the&#xD;
      investigators propose to study the effects of Cox-II inhibitor using experimentally induced&#xD;
      hyperlipidemic rats. Plasma total cholesterol, LDL and triglyceride concentrations will be&#xD;
      determined before and after animals treated with cyclooxygenase-2 (COX-2) inhibitors.&#xD;
      Biochemical markers related to cardiovascular events including prostaglandin I2,&#xD;
      thromboxaneA2 and others will also be investigated. The investigators will also investigate&#xD;
      these biochemical markers in patients taking Celecoxib and NSAIDs. The investigators hope&#xD;
      these studies will reveal clinically useful biochemical markers for cardiovascular events in&#xD;
      patients taking Cox-II inhibitor.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2008</start_date>
  <completion_date type="Anticipated">February 2010</completion_date>
  <primary_completion_date type="Anticipated">February 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Arthritis</condition>
  <arm_group>
    <arm_group_label>RA with drug</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>RA without drug</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Arthritis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male/female age &gt;18&#xD;
&#xD;
          -  Clinical diagnosed of arthritis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Must not be pregnant/breastfeeding&#xD;
&#xD;
          -  Other conditions may lead to exclusion from the trial (e.g. Diabetes mellitus,&#xD;
             malignant melanoma, cardiac conduction disorders, hepatic/renal insufficiency.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>July 22, 2009</study_first_submitted>
  <study_first_submitted_qc>July 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2009</study_first_posted>
  <last_update_submitted>July 22, 2009</last_update_submitted>
  <last_update_submitted_qc>July 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2009</last_update_posted>
  <responsible_party>
    <name_title>En-Pei Isabel Chiang</name_title>
    <organization>National Chung Hsing University</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

